Amrutanjan Health Care Limited

BSE: AMRUTANJAN590006ISIN INE098F01031

Healthcare
Pharmaceuticals

BSE listing

Share price

₹493.65+3.45 (+0.70%)

as of 18 Sep 2026

52W high: ₹772.10
52W low: ₹476.85
Off 52W high: -36.06%
1M return: -0.63%
3M return: -9.70%
6M return: -3.85%
1Y return: -34.18%
20D avg volume: 3,763
50 DMA: ₹513.98
200 DMA: ₹568.04

Key ratios Standalone

Market cap: ₹1,443 Cr
Current price: ₹493.65
52W high / low: ₹772.10 / ₹476.85
Face value: ₹1.00
P/E: 26.44
P/B: 4.79
EPS (TTM): ₹18.67
Book value / share: ₹103.06
ROE: 18.12%
ROCE: 20.40%
Operating margin: 7.80%
Net margin: 4.24%
Debt / equity: 0.00
Net debt: ₹-11.27 Cr
Interest cover: 390.45
Dividend yield: 0.99%
Dividend / share (TTM): ₹4.90
Payout: 26.25%
Cash conversion cycle: 19.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	102.97	149.77	141.04	117.70	94.05	135.41	—
	3.81	4.73	4.12	4.30	4.43	4.82	—
	98.69	125.88	117.54	102.78	87.18	119.38	—
	25.76	31.30	28.77	25.12	21.24	34.95	—
	36.08	40.98	33.29	35.19	31.16	30.93	—
	17.62	15.65	16.15	15.95	16.01	16.02	—
	0.04	0.05	0.05	0.05	0.05	0.04	—
	1.92	1.61	1.62	1.56	1.53	1.62	—
	24.82	35.05	35.93	27.57	20.19	32.70	—
	8.10	28.62	27.62	19.21	11.29	20.86	—
	-2.03	-7.61	-1.25	0.00	0.00	0.00	—
	6.07	21.02	26.36	19.21	11.29	20.86	—
	1.70	4.82	6.91	5.25	2.98	5.68	—
	4.37	16.19	19.45	13.96	8.31	15.18	—
	1.51	5.60	6.73	4.83	2.87	5.25	—
Key metrics
	8.03	22.68	28.03	20.82	12.87	22.52	—
	7.80%	15.10%	19.90%	17.70%	13.70%	16.60%	—
	4.20%	10.80%	13.80%	11.90%	8.80%	11.20%	—
	—	5.50%	—	5.50%	—	6.20%	—
	9.50%	10.60%	—	—	—	—	—
	-47.40%	6.70%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	511.48	502.55	451.82	—
	16.96	17.57	17.68	—
	444.89	433.38	400.36	—
	110.95	106.43	100.60	—
	145.54	140.63	123.18	—
	65.37	63.76	59.10	—
	0.19	0.20	0.22	—
	6.71	6.32	6.53	—
	123.37	118.74	111.31	—
	83.55	86.74	69.13	—
	-10.89	-8.86	0.00	—
	72.66	77.89	69.13	—
	18.68	19.97	18.30	—
	53.97	57.92	50.83	—
	18.67	20.03	17.58	—
Key metrics
	79.56	84.41	75.88	—
	15.55%	16.80%	16.80%	—
	10.55%	11.50%	11.30%	—
	—	20.40%	20.60%	—
	—	11.20%	—	—
	—	13.90%	—	—
	—	-19.03	15.35	—
	—	0.62	1.00	—
	—	0.00	0.00	—
	—	-11.27	-10.16	—
	—	19.6	11.3	—
Balance sheet
	—	508.89	421.39	—
	—	291.65	290.67	—
	—	11.27	10.16	—
	—	60.64	55.82	—
	—	37.35	27.26	—
	—	14.91	8.26	—
	—	49.81	47.73	—
	—	70.89	69.04	—
	—	126.18	84.58	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	370.23	326.61	—
Cash flow
	—	35.97	50.90	—
	—	-21.23	-30.97	—
	—	-13.62	-13.49	—
	—	55.00	35.55	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 46.51%

Holder	Type	Holding	Previous	Change
GOODHEALTH HOLDINGS PRIVATE LIMITED	Promoter Group	20.15%	—	—
SAMBHUPRASAD SIVALENKA	Promoter	10.34%	—	—
RAMAA PRABHAKAR ARIKIREVULA	Promoter	7.76%	—	—
DSP SMALL CAP FUND	Public	3.80%	—	—
SAMBHU PRASAD SIVALENKA	Promoter	3.60%	—	—
CARNELIAN BHARAT AMRITKAAL FUND .	Public	2.98%	—	—
RAMALINGAM GANTI	Promoter	2.53%	—	—
AMULYA KAMAKSHI PRIYA ARIKIREVULA	Promoter	2.13%	—	—
ICICI PRUDENTIAL FMCG FUND	Public	2.01%	—	—
Investor Education and Protection Fund (IEPF)	Public	1.50%	—	—
DIPAK KANAYALAL SHAH	Public	1.12%	—	—
CARNELIAN STRUCTURAL SHIFT FUND	Public	1.09%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

BRSR Report for the financial year ended March 31, 2026.28 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report of 89th Annual General Meeting to be held on 23rd September 202628 Aug 2026 · Others / Reg. 34 (1) Annual Report
Investor Presentation for the Quarter Ended 30th June 202612 Aug 2026 · Company Update / General
Record Date for the Final Dividend and AGM11 Aug 2026 · Corp. Action / Record Date
Financial Results and Outcome of the Board Meeting11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 20156 Aug 2026 · Company Update / General
Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....5 Aug 2026 · Board Meeting / Board Meeting
Commissioning of New Manufacturing Facility5 Aug 2026 · Company Update / General
Announcement under Regulation 30 (LODR)- Credit Rating5 Aug 2026 · Company Update / Credit Rating
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others5 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of under Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20151 Aug 2026 · Company Update / General
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June 20268 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for Closure of Trading Window24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Outcome of Postal Ballot19 Jun 2026 · AGM/EGM / Postal Ballot
Voting results and the Scrutinizer Report of the Postal Ballot19 Jun 2026 · AGM/EGM / Postal Ballot
Annual Secretarial Compliance Report for the Financial Year Ended 31.03.202628 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Reconstitution Of Committees of Board of Directors27 May 2026 · Company Update / General
Completion of tenure of Mr. Raja Venkataraman as an Independent Director.26 May 2026 · Company Update / Change in Management
Postal Ballot Notice19 May 2026 · AGM/EGM / Postal Ballot
Notice of Postal Ballot18 May 2026 · AGM/EGM / Postal Ballot
Financial Results - Machine Readable Format13 May 2026 · Company Update / General
Investor Presentation for the Quarter and year ended 31st March 20269 May 2026 · Company Update / Investor Presentation
Intimation on rolling out of the revised Second Phase "ESOP 2" of the existing ESOP Scheme of the Company by the name of "Amrutanjan Health Care Limited - Employee Stock Option Scheme 2020".8 May 2026 · Company Update / General
Re-appointment of Mr. S Muralidharan as Non-Executive Independent Director w.e.f 29 June 2026.8 May 2026 · Company Update / Change in Management
Appointment of Mr. Ramaswami Krishnan as an Additional Director designated as Non-Executive Independent Director w.e.f 8 May 2026.8 May 2026 · Company Update / Change in Management
Outcome of Board Meeting8 May 2026 · Board Meeting / Outcome of Board Meeting
Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve Audited Financial Results ....30 Apr 2026 · Board Meeting / Board Meeting
Product Launch17 Apr 2026 · Company Update / General
Rephrasing of ESOP17 Apr 2026 · Company Update / General
Certificate Under Reg.74(5) of SEBI (DP) Regulation 20188 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window for the Quarter and Year Ending 31st March 202624 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").18 Mar 2026 · Company Update / General
Intimation of under Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").18 Mar 2026 · Company Update / General
Investor Presentation for the Quarter and Nine Months Ended 31st December 20254 Feb 2026 · Company Update / General
Record date for the second interim dividend is 7 February 2026.3 Feb 2026 · Corp. Action / Record Date
Board Meeting Outcome for Unaudited Financial Results for the Quarter and nine months ended December 31, 2025.3 Feb 2026 · Board Meeting / Outcome of Board Meeting
Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve the Unaudited Financial ....28 Jan 2026 · Board Meeting / Board Meeting
Certificate under Reg 74(5) of SEBI (DP) Regulations, 20188 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window for the Quarter Ending 31st December 202519 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Investor Presentation for the Quarter Ended 30th September 202511 Nov 2025 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.9000	11 Sep 2026	11 Sep 2026	—
Interim Dividend - Rs. - 1.0000	6 Feb 2026	7 Feb 2026	—
Interim Dividend - Rs. - 1.0000	18 Nov 2025	18 Nov 2025	—
Final Dividend - Rs. - 2.6000	16 Sep 2025	16 Sep 2025	—
Interim Dividend - Rs. - 1.0000	18 Feb 2025	18 Feb 2025	—
Interim Dividend - Rs. - 1.0000	22 Nov 2024	22 Nov 2024	—
Final Dividend - Rs. - 2.6000	13 Sep 2024	—	—

Board meetings

11 Aug 2026 Board Meeting - Financial Results